pubmed-article:14610008 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0020969 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0023828 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0020507 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0102118 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:14610008 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
pubmed-article:14610008 | pubmed:issue | 22 | lld:pubmed |
pubmed-article:14610008 | pubmed:dateCreated | 2003-12-5 | lld:pubmed |
pubmed-article:14610008 | pubmed:abstractText | Innate immunity is of major importance in vascular repair. The present study evaluated whether systemic and transient depletion of monocytes and macrophages with liposome-encapsulated bisphosphonates inhibits experimental in-stent neointimal formation. | lld:pubmed |
pubmed-article:14610008 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14610008 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14610008 | pubmed:language | eng | lld:pubmed |
pubmed-article:14610008 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14610008 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:14610008 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14610008 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14610008 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14610008 | pubmed:month | Dec | lld:pubmed |
pubmed-article:14610008 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:EdelmanElazer... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:GolombGershon... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:DanenbergHaim... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:SeifertPhilip... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:GaoJianchuanJ | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:GroothuisAdam... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:SwaminathanRa... | lld:pubmed |
pubmed-article:14610008 | pubmed:author | pubmed-author:EpsteinHilaH | lld:pubmed |
pubmed-article:14610008 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:14610008 | pubmed:day | 2 | lld:pubmed |
pubmed-article:14610008 | pubmed:volume | 108 | lld:pubmed |
pubmed-article:14610008 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14610008 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14610008 | pubmed:pagination | 2798-804 | lld:pubmed |
pubmed-article:14610008 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:meshHeading | pubmed-meshheading:14610008... | lld:pubmed |
pubmed-article:14610008 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14610008 | pubmed:articleTitle | Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. | lld:pubmed |
pubmed-article:14610008 | pubmed:affiliation | Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Mass 02139, USA. danen@mit.edu | lld:pubmed |
pubmed-article:14610008 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14610008 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:14610008 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14610008 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14610008 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14610008 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14610008 | lld:pubmed |